Michael A. Smith

Novel role for tumor suppressor gene, liver kinase B1, in epithelial–mesenchymal transition leading to chronic lung allograft dysfunction

A. Bharat, J. Eschbacher, T. Mohanakumar, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.

T. Fleming, T. Mohanakumar, Wei Liu, 2021, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Loss of IGFBP2 mediates alveolar type 2 cell senescence and promotes lung fibrosis

D. Flint, M. Kearney, T. Mohanakumar, 2023, Cell reports. Medicine.

Low‐dose IL‐2 prevents murine chronic cardiac allograft rejection: Role for IL‐2‐induced T regulatory cells and exosomes with PD‐L1 and CD73

A. Bharat, T. Mohanakumar, R. Ravichandran, 2022, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Circulating exosomes induced by respiratory viral infections in lung transplant recipients activate cellular stress, innate immune pathways and epithelial to mesenchymal transition.

A. Bharat, A. Limaye, T. Fleming, 2021, Transplant immunology.

Cytosolic EpCAM cooperates with H-Ras to regulate epithelial to mesenchymal transition through ZEB1

W. Gillanders, R. Bremner, N. Sankpal, 2023, PloS one.

Downregulation of a tumor suppressor gene LKB1 in lung transplantation as a biomarker for chronic murine lung allograft rejection.

A. Bharat, T. Mohanakumar, R. Ravichandran, 2023, Cellular immunology.

CLOTRIMAZOLE INHIBITS LUNG FIBROBLAST PROLIFERATION IN VITRO: Implications for Use in the Prevention and Treatment of Obliterative Bronchiolitis After Lung Transplantation1

J. Cooper, G. Patterson, T. Mohanakumar, 2000, Transplantation.

Hospitalized patients with irreversible lung injury from COVID-19 have higher morbidity but similar 1-year survival after lung transplant compared to hospitalized patients transplanted for restrictive lung disease

R. Bremner, R. Walia, S. Tokman, 2022, The Journal of Heart and Lung Transplantation.